Literature DB >> 22981238

Possibly lifesaving, noninvasive, EEG-guided neuromodulation in anesthesia-refractory partial status epilepticus.

Magnus Thordstein1, Radu Constantinescu.   

Abstract

This study aimed to investigate the effect of low frequency repetitive transcranial magnetic stimulation (rTMS) guided as to localization and effect by continuous EEG on a super-refractory status epilepticus unresponsive to conventional treatment for 44 days including repeated deep sedation. Repetitive transcranial magnetic stimulation was delivered for one-hour sessions to the most active of two EEG foci for 8 days. From the third day of stimulation, the EEG pathology markedly decreased in parallel to clinical improvement. The patient could be weaned off the respirator, transferred to an ordinary ward then to a rehabilitation clinic. This is the first report of a positive outcome of rTMS treatment in super-refractory status epilepticus. In the context of refractory partial status epilepticus, neuromodulation through rTMS is a safe treatment option. If performed along the lines herein described, it may also be more efficient than conventional treatment. Repetitive transcranial magnetic stimulation may be an underused treatment option for status epilepticus.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22981238     DOI: 10.1016/j.yebeh.2012.07.026

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  11 in total

Review 1.  Refractory and super-refractory status epilepticus--an update.

Authors:  Sara Hocker; William O Tatum; Suzette LaRoche; W David Freeman
Journal:  Curr Neurol Neurosci Rep       Date:  2014-06       Impact factor: 5.081

Review 2.  Super-Refractory Status Epilepticus.

Authors:  Mauricio Ruiz Cuero; Panayiotis N Varelas
Journal:  Curr Neurol Neurosci Rep       Date:  2015-11       Impact factor: 5.081

3.  Repetitive transcranial magnetic stimulation; A cost-effective and beneficial treatment option for refractory focal seizures.

Authors:  Stephen VanHaerents; Susan T Herman; Trudy Pang; Alvaro Pascual-Leone; Mouhsin M Shafi
Journal:  Clin Neurophysiol       Date:  2014-12-15       Impact factor: 3.708

Review 4.  Neurostimulation as a Method of Treatment and a Preventive Measure in Canine Drug-Resistant Epilepsy: Current State and Future Prospects.

Authors:  Marta Nowakowska; Muammer Üçal; Marios Charalambous; Sofie F M Bhatti; Timothy Denison; Sebastian Meller; Gregory A Worrell; Heidrun Potschka; Holger A Volk
Journal:  Front Vet Sci       Date:  2022-06-16

5.  The Hemiconvulsions-Hemiplegia-Epilepsy (HHE) syndrome: a transcranial magnetic stimulation-EEG study.

Authors:  V K Kimiskidis; K Sotirakoglou; D A Kazis; V Papaliagkas; E Chatzikyriakou
Journal:  Hippokratia       Date:  2017 Apr-Jun       Impact factor: 0.471

6.  Transcranial magnetic stimulation for refractory focal status epilepticus in the intensive care unit.

Authors:  Anli Liu; Trudy Pang; Susan Herman; Alvaro Pascual-Leone; Alexander Rotenberg
Journal:  Seizure       Date:  2013-07-19       Impact factor: 3.184

Review 7.  Transcranial Magnetic Stimulation for Status Epilepticus.

Authors:  F A Zeiler; M Matuszczak; J Teitelbaum; L M Gillman; C J Kazina
Journal:  Epilepsy Res Treat       Date:  2015-11-22

Review 8.  Novel Neuromodulation Techniques to Assess Interhemispheric Communication in Neural Injury and Neurodegenerative Diseases.

Authors:  Samuel S Shin; Galit Pelled
Journal:  Front Neural Circuits       Date:  2017-03-09       Impact factor: 3.492

Review 9.  Super-Refractory Status Epilepticus: Prognosis and Recent Advances in Management.

Authors:  Batool F Kirmani; Katherine Au; Lena Ayari; Marita John; Padmashri Shetty; Robert J Delorenzo
Journal:  Aging Dis       Date:  2021-07-01       Impact factor: 6.745

10.  Suppression of motor cortical excitability in anesthetized rats by low frequency repetitive transcranial magnetic stimulation.

Authors:  Paul A Muller; Sameer C Dhamne; Andrew M Vahabzadeh-Hagh; Alvaro Pascual-Leone; Frances E Jensen; Alexander Rotenberg
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.